Joo Y. Song
City of Hope National Medical Center
PathologyOncologyAntigenImmunologyT cellFollicular lymphomaMantle cell lymphomaB cellLeukemiaDiffuse large B-cell lymphomaAutologous stem-cell transplantationLymphomaBone marrowPopulationTransplantationGene rearrangementCancer researchCD30MedicineBiology
97Publications
17H-index
1,159Citations
Publications 95
Newest
#1Ha Nguyen (City of Hope National Medical Center)H-Index: 1
#2Anamarija M. Perry (UM: University of Michigan)H-Index: 17
Last. Joo Y. Song (City of Hope National Medical Center)H-Index: 17
view all 14 authors...
Abstract The prognosis of diffuse large B-cell lymphoma (DLBCL) has been associated with clinical parameters, cell of origin (COO), and various genetic aberrations. Recently, a NanoString gene expression assay (DLBCL90) was developed which identifies DLBCL cases with an outcome similar to those with double- or triple-hit DLBCL with both MYC and BCL2 rearrangements. We carried out this study to validate the predictive ability of the DLBCL90 assay in an independent cohort of patients with the germ...
Source
#1Joo Y. Song (City of Hope National Medical Center)H-Index: 17
#2Anamarija M. Perry (UM: University of Manitoba)H-Index: 17
Last. Dennis D. Weisenburger (City of Hope National Medical Center)H-Index: 38
view all 24 authors...
Purpose: We performed detailed genomic analysis on 87 cases of de novo diffuse large B-cell lymphoma of germinal center type (GCB DLBCL) to identify characteristics that are associated with survival in those treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). Experimental Design: The cases were extensively characterized by combining the results of immunohistochemistry, cell-of-origin gene expression profiling (Nanostring), double-hit gene expression profi...
Source
#1Joo Y. Song (City of Hope National Medical Center)H-Index: 17
#2Anamarija M. Perry (UM: University of Michigan)H-Index: 17
Last. Dennis D. Weisenburger (City of Hope National Medical Center)H-Index: 38
view all 24 authors...
Source
#1Ha Nguyen (City of Hope National Medical Center)H-Index: 1
#2Joo Y. Song (City of Hope National Medical Center)H-Index: 17
Abstract There are multiple entities that involve the lung that have radiographic, clinical, and morphologic overlaps with pulmonary lymphoma. In this review, we will discuss these entities in detail and provide relevant updates.
2 CitationsSource
#1Ibrahim AldossH-Index: 18
#2Joo Y. Song (City of Hope National Medical Center)H-Index: 17
Last. Stephen J. FormanH-Index: 94
view all 4 authors...
Source
#1Monzr M. Al Malki (City of Hope National Medical Center)H-Index: 17
#2Joo Y. Song (City of Hope National Medical Center)H-Index: 17
Last. Vinod Pullarkat (City of Hope National Medical Center)H-Index: 35
view all 14 authors...
Abstract The negative impact of Iron overload (IO) on outcomes of allogeneic hematopoietic cell transplantation (HCT) is well-recognized, but its impact on umbilical cord blood (UCB) transplant outcome is unknown. We retrospectively analyzed outcomes of 150 patients who received UCB-HCT at our institution, stratified by pre-HCT serum ferritin level (SF) of 2000 ng/ml. Two-year overall survival rate among patients with SF >2000 and ≤2000 ng/ml was 26.1% (95%CI: 10.6%-44.7%) and 52.1% (95%CI: 40.1...
3 CitationsSource
#1Ibrahim Aldoss (City of Hope National Medical Center)H-Index: 18
#2Mary C. Clark (City of Hope National Medical Center)H-Index: 1
Last. Vinod Pullarkat (City of Hope National Medical Center)H-Index: 35
view all 4 authors...
The IL-3 alpha chain receptor (CD123) is a cell surface protein that is widely expressed by various subtypes of acute leukemia, including acute myeloid leukemia (AML), acute lymphoblastic leukemia and blastic plasmacytoid dendritic cell neoplasm. Notably, CD123 is preferentially overexpressed in leukemia stem cells (LSC) in contrast to normal hematopoietic stem cells, and this differential expression allows for the selective eradication of LSC and leukemic blasts through therapeutic targeting of...
1 CitationsSource
#1Daniel O. Persky (UA: University of Arizona)H-Index: 24
#2Hongli Li (Fred Hutchinson Cancer Research Center)H-Index: 12
Last. Jonathan W. Friedberg (UR: University of Rochester)H-Index: 59
view all 19 authors...
PURPOSEDiffuse large B-cell lymphoma (DLBCL) presents as a limited-stage disease in 25% to 30% of patients, with better overall survival (OS) than that for advanced-stage disease but with continuou...
9 CitationsSource
Source
#1Cosimo Di Raimondo (City of Hope National Medical Center)H-Index: 7
#2Vishwas Parekh (City of Hope National Medical Center)H-Index: 15
Last. Farah R. Abdulla (City of Hope National Medical Center)H-Index: 3
view all 8 authors...
PURPOSE OF REVIEW: Primary cutaneous CD30+ T-cell lymphoproliferative disorders (CD30+ LPDs) are the second most common cutaneous lymphomas after mycosis fungoides and Sezary syndrome. They include primary cutaneous anaplastic large cell lymphoma (pcALCL), lymphomatoid papulosis (LyP), and borderline lesions. The purpose of this literature review is to consolidate the available evidence on the primary cutaneous CD30+ LPD in order to define the tools for correct diagnosis and appropriate treatmen...
2 CitationsSource
12345678910
Close Researchers